Clinical characteristics of multisystem inflammatory syndrome in adults: a systematic review

P Patel, J DeCuir, J Abrams, AP Campbell… - JAMA network …, 2021 - jamanetwork.com
Importance Multisystem inflammatory syndrome in adults (MIS-A) has not been well
described. Improved diagnosis and treatment of MIS-A might mitigate COVID-19 morbidity …

A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies

M Kumari, RM Lu, MC Li, JL Huang, FF Hsu… - Journal of biomedical …, 2022 - Springer
The novel coronavirus disease (COVID-19) pandemic remains a global public health crisis,
presenting a broad range of challenges. To help address some of the main problems, the …

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

CR Wolfe, KM Tomashek, TF Patterson… - The lancet respiratory …, 2022 - thelancet.com
Background Baricitinib and dexamethasone have randomised trials supporting their use for
the treatment of patients with COVID-19. We assessed the combination of baricitinib plus …

Potential of sulforaphane as a natural immune system enhancer: A review

A Mahn, A Castillo - Molecules, 2021 - mdpi.com
Brassicaceae are an outstanding source of bioactive compounds such as ascorbic acid,
polyphenols, essential minerals, isothiocyanates and their precursors, glucosinolates (GSL) …

Contribution of STAT3 to the pathogenesis of COVID-19

A Jafarzadeh, M Nemati, S Jafarzadeh - Microbial pathogenesis, 2021 - Elsevier
Hyper-inflammatory responses, lymphopenia, unbalanced immune responses, cytokine
storm, large viral replication and massive cell death play fundamental roles in the …

Diverse immunological factors influencing pathogenesis in patients with COVID-19: a review on viral dissemination, immunotherapeutic options to counter cytokine …

AA Rabaan, SH Al-Ahmed, MA Garout, AM Al-Qaaneh… - Pathogens, 2021 - mdpi.com
The pathogenesis of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is still not fully unraveled. Though …

Immune landscape and redox imbalance during neurological disorders in COVID-19

A Thakur, V Sharma, S Averbek, L Liang… - Cell death & …, 2023 - nature.com
Abstract The outbreak of Coronavirus Disease 2019 (COVID-19) has prompted the scientific
community to explore potential treatments or vaccines against severe acute respiratory …

The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis

M Golpour, T Mousavi… - International …, 2021 - journals.sagepub.com
A recently discovered coronavirus, SARS-CoV-2, caused a global respiratory disease
pandemic called COVID-19. Many studies have shown the excessive activation of the innate …

Systems-level profiling of early peripheral host-response landscape variations across COVID-19 severity states in an Indian cohort

U Banerjee, S Chunchanur, KN Balaji, A Singh… - Genes & …, 2023 - nature.com
Host immune response to COVID-19 plays a significant role in regulating disease severity.
Although big data analysis has provided significant insights into the host biology of COVID …

Therapeutic and palliative role of a Unani herbal decoction in COVID-19 and similar respiratory viral illnesses: Phytochemical & pharmacological perspective

M Fazil, S Nikhat - Journal of Ethnopharmacology, 2022 - Elsevier
Ethnopharmacological relevance Outbreaks of respiratory viral infections like Severe Acute
Respiratory Syndrome, Middle-East Respiratory Syndrome, and Coronavirus Disease-2019 …